TAPUR Study - FDA approved therapies   Targeted therapies such as BRAF, CDK2NA, etc.

TAPUR Study - FDA approved therapies Targeted therapies such as BRAF, CDK2NA, etc.

User Photo
moasc

2 years
68 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Omid Hamid MD
Chief, Translational Research/Immuno-Oncology
Director shares, TAPUR Study - FDA approved therapies Targeted therapies such as BRAF, CDK2NA, etc. at the 2018 Oncology Summit in Huntington Beach, CA

Go to: http://www.moasc.org for more information
Up Next Autoplay